BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.35) by 51.43 percent. This is a 86.72 percent increase over losses of $(3.99) per share from the same period last year. The company reported quarterly sales of $1.46 million which missed the analyst consensus estimate of $2.29 million by 36.15 percent. This is a 19.88 percent decrease over sales of $1.83 million the same period last year.